KIT


Summary: This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in KIT


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP TAS GO:0000165 MAPK cascade
BP IDA GO:0000187 activation of MAPK activity
BP ISS GO:0001541 ovarian follicle development
BP IEA GO:0002318 myeloid progenitor cell differentiation
BP IEA GO:0002320 lymphoid progenitor cell differentiation
BP ISS GO:0002327 immature B cell differentiation
Showing 1 to 6 of 114 rows rows per page

Gene expression in normal tissue: KIT

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in KIT


Loading, please wait...
Database
Pathway ID
Pathway Des.
pid cmyb_pathway C-MYB transcription factor network
pid kitpathway Signaling events mediated by Stem cell factor receptor (c-Kit)
pharmgkb PA164713427 Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
pharmgkb PA165959425 Pathway_PA165959425
pharmgkb PA165959584 Sorafenib Pharmacodynamics
netpath Pathway_EGFR1 EGFR1
Showing 1 to 6 of 57 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD193 Fqi1 3
iGMDRD152 179324-69-7 4
iGMDRD61 Kinetin riboside 2
iGMDRD446 LY 2183240 1
Showing 1 to 4 of 57 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in KIT

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​